The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II clinical trial of metformin combined with FOLFIRI plus bevacizumab as second-line therapy in patients with RAS-mutant metastatic colorectal cancer.
 
Wen-zhuo He
No Relationships to Disclose
 
Chang Jiang
No Relationships to Disclose
 
Jiahong Yi
No Relationships to Disclose
 
Ju Xue
No Relationships to Disclose
 
Zhao-feng Yin
No Relationships to Disclose
 
Wen-jing Dong
No Relationships to Disclose
 
Liang-Ping Xia
No Relationships to Disclose